 WALTHAM, Mass., May 25, 2021 GLOBE NEWSWIRE -- Repligen Corporation NASDAQ:RGEN, a life sciences company focused on bioprocessing technology leadership, today announced that it will present virtually at two upcoming investor conferences. 